Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 21 April 2022
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences’s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications
Press Release, 16 March 2022
Kuros Biosciences reports results for the full year 2021
Kuros Annual Report, 2021
English version
Press Release, 3 February 2022
Kuros Biosciences’s MagnetOs Granules cleared by FDA for expanded spinal indications
Press Release, 20 January 2022
Kuros Biosciences publishes first-in-human clinical data for Fibrin-PTH (KUR-113) in treatment of open tibial shaft fractures
Press Release, 26 October 2021
Kuros Biosciences reports continued increase in MagnetOs U.S. sales